Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01380886 · ClinicalTrials.gov registry record · Phase 3
Growth and Tolerance of Young Infants Fed Infant Formulas
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 209
- Enrollment target
NCT01380886 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 209 participants.
The verdict
NCT01380886, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 209 participants
- Enrollment target
Study Summary
This is a randomized, multi-center, double blind, parallel study to compare growth and tolerance of healthy term infants fed either control or experimental infant formula.
Interventions
- OTHER experimental infant formula with alternate protein source
- OTHER Infant formula powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01380886
The ClinicalTrials.gov registry entry for NCT01380886 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Nutrition, which has 89 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which experimental infant formula with alternate protein source is the first listed.
NCT01380886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01380886 about?
NCT01380886 is a clinical study titled "Growth and Tolerance of Young Infants Fed Infant Formulas". This is a randomized, multi-center, double blind, parallel study to compare growth and tolerance of healthy term infants fed either control or experimental infant formula.
What is the current status of trial NCT01380886?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 209 participants. The study started on 2011-06. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01380886?
The interventions under investigation include: experimental infant formula with alternate protein source (OTHER), Infant formula powder (OTHER).
Who is sponsoring clinical trial NCT01380886?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.